SSTR2 and neoplasm: Based on our studies, this novel formulation displayed high selectivity to SSTR2-expressing tumor cells, significantly inhibited cell proliferation, and increased drug cytotoxicity, demonstrating superior tumor suppression effects compared to the non-targeting formulations, with the possibility of maintaining limited toxicity on healthy organs.